标题
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2016-06-22
DOI
10.3389/fphar.2016.00160
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice
- (2016) A. Nai et al. BLOOD
- Minihepcidin peptides as disease modifiers in mice affected by -thalassemia and polycythemia vera
- (2016) C. Casu et al. BLOOD
- Hepcidin regulation in the anemia of inflammation
- (2016) Chia-Yu Wang et al. CURRENT OPINION IN HEMATOLOGY
- Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels
- (2016) S. Kovac et al. HAEMATOLOGICA
- Haemochromatosis
- (2016) Lawrie W Powell et al. LANCET
- Iron and the liver
- (2016) Antonello Pietrangelo LIVER INTERNATIONAL
- Hepcidin
- (2016) Jing Liu et al. MEDICINE
- Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels
- (2016) S. Kovac et al. HAEMATOLOGICA
- High Sulfation and a High Molecular Weight Are Important for Anti-hepcidin Activity of Heparin
- (2016) Michela Asperti et al. Frontiers in Pharmacology
- Anti-repulsive Guidance Molecule C (RGMc) Antibodies Increases Serum Iron in Rats and Cynomolgus Monkeys by Hepcidin Downregulation
- (2015) Preethne Böser et al. AAPS Journal
- Hepatic Hepcidin Protects against Polymicrobial Sepsis in Mice by Regulating Host Iron Status
- (2015) CongLi Zeng et al. ANESTHESIOLOGY
- Small cyclic agonists of iron regulatory hormone hepcidin
- (2015) Kristine Chua et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia
- (2015) C. Guida et al. BLOOD
- Ineffective erythropoiesis and regulation of iron status in iron loading anaemias
- (2015) Clara Camaschella et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer
- (2015) Lia Tesfay et al. CANCER RESEARCH
- Hepcidin-Induced Hypoferremia Is a Critical Host Defense Mechanism against the Siderophilic Bacterium Vibrio vulnificus
- (2015) João Arezes et al. Cell Host & Microbe
- Ironing out Ferroportin
- (2015) Hal Drakesmith et al. Cell Metabolism
- Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease
- (2015) C. Casper et al. CLINICAL CANCER RESEARCH
- New insights into iron regulation and erythropoiesis
- (2015) Airie Kim et al. CURRENT OPINION IN HEMATOLOGY
- Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin
- (2015) Antonello Pietrangelo GASTROENTEROLOGY
- Progesterone receptor membrane component-1 regulates hepcidin biosynthesis
- (2015) Xiang Li et al. JOURNAL OF CLINICAL INVESTIGATION
- A holistic approach to targeting disease with polymeric nanoparticles
- (2015) Christopher J. Cheng et al. NATURE REVIEWS DRUG DISCOVERY
- The iron-regulatory hormone hepcidin: A possible therapeutic target?
- (2015) Luc Rochette et al. PHARMACOLOGY & THERAPEUTICS
- Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function
- (2015) Samira Lakhal-Littleton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anemia of Chronic Disorders: New Diagnostic Tools and New Treatment Strategies
- (2015) Guenter Weiss SEMINARS IN HEMATOLOGY
- Modulation of hepcidin to treat iron deregulation: potential clinical applications
- (2015) Nicole L. Blanchette et al. Expert Review of Hematology
- Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo
- (2014) Maura Poli et al. BIOCHEMICAL PHARMACOLOGY
- Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling
- (2014) K. Mleczko-Sanecka et al. BLOOD
- Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans
- (2014) L. T. van Eijk et al. BLOOD
- Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo
- (2014) M. Poli et al. BLOOD
- A chemical screen identifies small molecules that regulate hepcidin expression
- (2014) Vera Gaun et al. BLOOD CELLS MOLECULES AND DISEASES
- Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia of inflammation
- (2014) C. Mayeur et al. HAEMATOLOGICA
- Iron-Refractory Iron Deficiency Anemia (IRIDA)
- (2014) Matthew M. Heeney et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Modulation of Hepcidin as Therapy for Primary and Secondary Iron Overload Disorders
- (2014) Paul J. Schmidt et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- The pathophysiology and pharmacology of hepcidin
- (2014) Piotr Ruchala et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Hepcidin antagonists for potential treatments of disorders with hepcidin excess
- (2014) Maura Poli et al. Frontiers in Pharmacology
- Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells
- (2013) Wen Guo et al. AGING CELL
- A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates
- (2013) K. S. Cooke et al. BLOOD
- The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys
- (2013) F. Schwoebel et al. BLOOD
- The small molecule, genistein, increases hepcidin expression in human hepatocytes
- (2013) Aileen W. Zhen et al. HEPATOLOGY
- Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin
- (2013) Chloé Latour et al. HEPATOLOGY
- Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
- (2013) Shuling Guo et al. JOURNAL OF CLINICAL INVESTIGATION
- Liver as a target for oligonucleotide therapeutics
- (2013) Alfica Sehgal et al. JOURNAL OF HEPATOLOGY
- Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells
- (2013) Pamela Urrutia et al. JOURNAL OF NEUROCHEMISTRY
- Suppression of Iron-Regulatory Hepcidin by Vitamin D
- (2013) J. Bacchetta et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats
- (2013) Chia Chi Sun et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Systemic Iron Homeostasis
- (2013) Tomas Ganz PHYSIOLOGICAL REVIEWS
- Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial
- (2013) Mittie K. Doyle et al. RHEUMATOLOGY
- Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients
- (2013) Soken-Nakazawa J Song et al. ARTHRITIS RESEARCH & THERAPY
- Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis
- (2013) John D Isaacs et al. ARTHRITIS RESEARCH & THERAPY
- Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis
- (2012) E. Ramos et al. BLOOD
- An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe-/- mice and ameliorates anemia and iron overload in murine -thalassemia intermedia
- (2012) P. J. Schmidt et al. BLOOD
- Deletion of TMPRSS6 attenuates the phenotype in a mouse model of -thalassemia
- (2012) A. Nai et al. BLOOD
- 17β-Estradiol Inhibits Iron Hormone Hepcidin Through an Estrogen Responsive Element Half-Site
- (2012) Qing Yang et al. ENDOCRINOLOGY
- Hepcidin is a Potential Regulator of Iron Status in Chronic Kidney Disease
- (2012) Ken Tsuchiya et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis
- (2011) Omar Saeed et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Regulation of iron transport and the role of transferrin
- (2011) Konstantinos Gkouvatsos et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- -thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism
- (2011) Y. Ginzburg et al. BLOOD
- Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation
- (2011) T. S. Perlstein et al. BLOOD
- Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice
- (2011) K. E. Finberg et al. BLOOD
- Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats
- (2011) I. Theurl et al. BLOOD
- Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation
- (2011) A. U. Steinbicker et al. BLOOD
- Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload
- (2011) Gloria C. Preza et al. JOURNAL OF CLINICAL INVESTIGATION
- Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice
- (2011) Giada Sebastiani et al. Metallomics
- Host-mediated regulation of superinfection in malaria
- (2011) Silvia Portugal et al. NATURE MEDICINE
- Investigation of a Researcher's Death Due to Septicemic Plague
- (2011) Karen M. Frank et al. NEW ENGLAND JOURNAL OF MEDICINE
- AG490: An inhibitor of hepcidin expressionin vivo
- (2011) Shu-Ping Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia
- (2010) B. J. Sasu et al. BLOOD
- Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo
- (2010) M. Poli et al. BLOOD
- Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease
- (2010) S.-N. J. Song et al. BLOOD
- BMP6 Treatment Compensates for the Molecular Defect and Ameliorates Hemochromatosis in Hfe Knockout Mice
- (2010) Elena Corradini et al. GASTROENTEROLOGY
- Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells
- (2010) J.H. Boergermann et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice
- (2010) Sara Gardenghi et al. JOURNAL OF CLINICAL INVESTIGATION
- Ferroportin disease: A systematic meta-analysis of clinical and molecular findings
- (2010) Roman Mayr et al. JOURNAL OF HEPATOLOGY
- Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form
- (2010) Nadia Fatih et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Iron-Deficiency Anemia in Castleman Disease: Implication of the Interleukin 6/Hepcidin Pathway
- (2010) J.-B. Arlet et al. PEDIATRICS
- Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
- (2010) Z. K. Pinnix et al. Science Translational Medicine
- Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
- (2009) Misato Hashizume et al. RHEUMATOLOGY INTERNATIONAL
- Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator
- (2008) Y. Jiao et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search